AAAAAA
Results:
1-13
|
Results: 13
Authors:
GAUTHEROT E
LEDOUSSAL JM
BOUHOU J
MANETTI C
MARTIN M
ROUVIER E
BARBET J
Citation: E. Gautherot et al., DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS, The Journal of nuclear medicine, 39(11), 1998, pp. 1937-1943
Authors:
AURELI T
DICOCCO ME
PUCETTI C
RICCIOLINI R
SCALIBASTRI M
MICCHELI A
MANETTI C
CONTI F
Citation: T. Aureli et al., ACETYL-L-CARNITINE MODULATES GLUCOSE-METABOLISM AND STIMULATES GLYCOGEN-SYNTHESIS IN RAT-BRAIN, Brain research, 796(1-2), 1998, pp. 75-81
Authors:
GAUTHEROT E
BOUHOU J
LOUCIF E
MANETTI C
MARTIN M
LEDOUSSAL JW
ROUVIER E
BARBET J
Citation: E. Gautherot et al., RADIOIMMUNOTHERAPY OF LS174T COLON-CARCINOMA IN NUDE-MICE USING AN IODINE-131-LABELED BIVALENT HAPTEN COMBINED WITH AN ANTI-CEA X ANTI-INDIUM-DTPA BISPECIFIC ANTIBODY, The Journal of nuclear medicine, 38(5), 1997, pp. 18-18
Authors:
MANETTI C
ROUVIER E
GAUTHEROT E
LOUCIF E
BARBET J
LEDOUSSAL JM
Citation: C. Manetti et al., TARGETING BCL1 LYMPHOMA WITH ANTIIDIOTYPE ANTIBODIES - BIODISTRIBUTION KINETICS OF DIRECTLY LABELED ANTIBODIES AND BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS, International journal of cancer, 71(6), 1997, pp. 1000-1009
Authors:
GAUTHEROT E
BOUHOU J
LEDOUSSAL JM
MANETTI C
MARTIN M
ROUVIER E
BARBET J
Citation: E. Gautherot et al., THERAPY FOR COLON-CARCINOMA XENOGRAFTS WITH BISPECIFIC ANTIBODY-TARGETED, IODINE-131-LABELED BIVALENT HAPTEN, Cancer, 80(12), 1997, pp. 2618-2623
Authors:
GIULIANI A
MANETTI C
Citation: A. Giuliani et C. Manetti, HIDDEN PECULIARITIES IN THE POTENTIAL-ENERGY TIME-SERIES OF A TRIPEPTIDE HIGHLIGHTED BY A RECURRENCE PLOT ANALYSIS - A MOLECULAR-DYNAMICS SIMULATION, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 53(6), 1996, pp. 6336-6340
Authors:
MANETTI C
ROUVIER E
GAUTHEROT E
LOUCIF E
LEDOUSSAL JM
MARTIN M
BARBET J
Citation: C. Manetti et al., RADIOIMMUNOTHERAPY OF BCL1 LYMPHOMA WITH BISPECIFIC ANTIBODIES AND IODINE-131-LABELED BIVALENT HAPTENS, The Journal of nuclear medicine, 37(5), 1996, pp. 505-505
Authors:
MANETTI C
FOGLIANO V
RITIENI A
SANTINI A
RANDAZZO G
LOGRIECO A
MANNINA L
SEGRE AL
Citation: C. Manetti et al., DETERMINATION OF THE STRUCTURE OF FUSAPROLIFERIN BY H-1-NMR AND DISTANCE GEOMETRY, Structural chemistry, 6(3), 1995, pp. 183-189
Authors:
MANETTI C
LEDOUSSAL JM
ROUVIER E
GRUAZGUYON A
BARBET J
Citation: C. Manetti et al., INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS, International journal of cancer, 63(2), 1995, pp. 250-256
Authors:
BALLIO A
BOSSA F
DIGIORGIO D
DINOLA A
MANETTI C
PACI M
SCALONI A
SEGRE AL
Citation: A. Ballio et al., SOLUTION CONFORMATION OF THE PSEUDOMONAS-SYRINGAE PV SYRINGAE PHYTOTOXIC LIPODEPSIPEPTIDE SYRINGOPEPTIN 25-A - 2-DIMENSIONAL NMR, DISTANCE GEOMETRY AND MOLECULAR-DYNAMICS, European journal of biochemistry, 234(3), 1995, pp. 747-758
Authors:
BALLIO A
COLLINA A
DINOLA A
MANETTI C
PACI M
SEGRE A
Citation: A. Ballio et al., DETERMINATION OF STRUCTURE AND CONFORMATION IN SOLUTION OF SYRINGOTOXIN, A LIPODEPSIPEPTIDE FROM PSEUDOMONAS-SYRINGAE PV SYRINGAE BY 2D NMRAND MOLECULAR-DYNAMICS, Structural chemistry, 5(1), 1994, pp. 43-50
Authors:
MICCHELI A
TOMASSINI A
RICCIOLINI R
DICOCCO ME
PICCOLELLA E
MANETTI C
CONTI F
Citation: A. Miccheli et al., DEXAMETHASONE-DEPENDENT MODULATION OF CHOLESTEROL LEVELS IN HUMAN LYMPHOBLASTOID B-CELL LINE THROUGH SPHINGOSINE PRODUCTION, Biochimica et biophysica acta. Molecular cell research, 1221(2), 1994, pp. 171-177
Authors:
PESCOSOLIDO N
ACCORINTI M
DELFINI M
GUGLIELMELLI F
LAZZARI M
MANETTI C
MICCHELI A
Citation: N. Pescosolido et al., CLOBETASONE-17-BUTYRATE AND CATARACT P-13, H-1, C-13 NMR-STUDY, Drug investigation, 6(2), 1993, pp. 83-89
Risultati:
1-13
|